iGan Partners

Sam Ifergan, President and CEO, leads investment decisions and maintains board representation across the portfolio. Ifergan founded the firm in 2012 following an earlier career as an angel investor and technology operator. The firm operates with a lean partnership structure where the investment committee process is tightly coupled with Ifergan's own investment judgment and operational involvement.

iGan relies heavily on Ifergan's long-standing network within the Toronto-Waterloo startup corridor and relationships with Canadian incubators and accelerators. The firm's reputation as a hands-on lead investor — rather than a passive capital provider — draws founder referrals from prior portfolio exits. It does not publicly disclose a formal scouting network or university partnership program, though its proximity to University of Toronto and University of Waterloo startup ecosystems is a structural input to sourcing.

iGan operates as a traditional institutional venture capital firm rather than a single-family office. It raises committed capital from limited partners and deploys it through a standard fund structure with management fees and carried interest. While Sam Ifergan is the anchoring figure and likely a significant personal capital contributor, the firm is an asset manager organized as a private equity entity — not a family office vehicle.

iGan primarily executes direct investments into operating companies, typically leading seed and Series A rounds. There is no public record of the firm operating as a fund-of-funds or making material LP commitments to other venture managers. Its co-investment activity occurs alongside peer venture firms on a deal-by-deal basis, as seen in rounds where US funds come in as follow-on investors.

The firm focuses on early-stage companies at the seed, startup, and early growth phases, with occasional participation in expansion and late-stage rounds for existing portfolio holdings. iGan's core check size typically corresponds to Series A lead investments in the CAD 1-5 million range, though precise figures are not publicly disclosed. The firm occasionally writes seed-stage checks for companies in its core technology verticals.

iGan does not publicly list excluded sectors, but its investment record shows no activity in resource extraction, consumer packaged goods, retail, or traditional manufacturing. The firm's portfolio is consistently concentrated in B2B technology — enterprise software, cybersecurity, digital health, AI/ML, and IoT. Life sciences and drug development are notably absent from its deal history despite the broader digital health interest.

iGan operates independently in the Toronto venture ecosystem, without formal affiliations to larger platforms like OMERS Ventures, Georgian, or Real Ventures. The firm co-invests with peer funds on a transactional basis and maintains its own limited partner base. No spinout relationship exists with a prior institution — the firm was built from Ifergan's personal angel investing activity rather than as a breakaway vehicle from an established manager.